Target Binding Experiments

Case: In vitro pharmacological efficacy assay of DS-8201a (an ADC drug targeting HER2). 


图片16.png图片8.png

Fig. Binding assay of DS-8201a in different cancer cell lines


GPT Advantages


  • Extensive library of target cells (300+ cancer cell lines and humanized cell lines) and certified BSL-2 level laboratories.

  • Free provision of comparator antibody therapy for common viral infections.

  • Proficient in Flow Cytometry and molecular analysis platforms.

  • Immune system humanized mice available for functional verification of Fc effects (ADCC, ADCP, etc.) on ADC drug antibodies, including NCG-IL15, NCG-IL2, and NCG-SGM3 models.

  • Vast project experience.

  • Compliance with regulatory requirements for new drug application submissions.

  • Strict laboratory data storage standards ensure experiment traceability.


TALK WITH OUR EXPERTS

GemPharmatech is committed to protecting and respecting your privacy, and we'll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please click below to say how you would like us to contact you:

In order to provide you with the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please click the checkbox below.

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.